The Technical AnalystExchange: Other OTC Sector: Healthcare Industry: Drug Manufacturers - General
Bristol-Myers Squibb Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $800.00
/ 11 apr 2024 @ 14:31
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 99 169 mill |
| EPS: | 0.225 |
| P/E: | 3 555.56 |
| Earnings Date: | Mar 30, 2023 |
| SharesOutstanding: | 123.96 mill |
| Avg Daily Volume: | 0.0000 mill |
| RATING 2024-04-11 |
|---|
| S |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Strong Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 3 555.56 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 3 555.56 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$330.66 (-58.67%) $-469.34 |
| Date: 2024-04-17 |
| Expected Trading Range (DAY) |
|---|
|
$ 792.95 - 807.06 ( +/- 0.88%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-01-01 | Poole Ahn Amanda | Buy | 0 | Common Stock, $0.10 par value |
| 2024-01-01 | Poole Ahn Amanda | Sell | 3 214 | Market Share Units |
| 2024-01-01 | Poole Ahn Amanda | Sell | 4 822 | Performance Shares |
| 2023-12-31 | Yale Phyllis R | Buy | 658 | Deferred Share Units |
| 2023-12-31 | Storch Gerald L | Buy | 706 | Deferred Share Units |
| INSIDER POWER |
|---|
| -20.48 |
| Last 94 transactions |
| Buy: 132 368 | Sell: 222 964 |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $800.00 (0.00% ) |
| Volume | 0.0000 mill |
| Avg. Vol. | 0.0000 mill |
| % of Avg. Vol | 300.00 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For BMYMP
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
BMYMP
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.